WASHINGTON (dpa-AFX) - With earnings season in full swing, investors are turning their attention to a quartet of healthcare and biotech names, BSX, MEDP, MOH, and TMO, set to report Q3 results on October 22. Wall Street analysts currently estimate earnings of $0.71 per share, with revenue expected to reach about $4.97 billion for the quarter. The company also projects third-quarter earnings per share on a GAAP basis to be in the range of $0.44 - $0.46. Thirty-two Wall Street analysts have a consensus earnings estimate of $2.98 per share on revenue of $19.88 billion for 2025. Wall Street analysts expect the company to report earnings of $3.57 per share and revenue of $640.98 million for the quarter.